Here, we provide evidence for the first time that PFKFB3 is upregulated in T2D HAECs and that downregulation of PFKFB3 via siRNA silencing or inhibition of glycolysis using the substrate-based analog, 2-DG, increases the levels of NO. The gene discussed is PFKFB3; the disease is type 2 diabetes mellitus.